Key Points

  • Studied in a pre-clinical in vitro human model of gut-skin axis
  • novaBLG1 helps to reduce pro-inflammatory pathways over the gut-skin axis and it promotes the correct balance of the intestinal microbiota
  • It works synergically when combined with GREENIURONIC
  • Scientific paper will be submitted shortly to peer-reviewed journal
  • Without food allergens Reg. 1169/2011

PROBIOTIC STRAIN FOR HEALTHIER SKIN

Bifidobacterium longum novaBLG1 (DSM 34338)

Recommended dosage: 1 billion cells per day (better combined with 100mg of Greeniuronic)

Scientific Data

B. Longum novaBLG1 has been selected among other probiotics for its anti-inflammatory properties and tested in combination with GREENIURONIC in a gut-skin model. Firstly, it was assessed the effect on gut-metabolism and then over a keratinocyte line.

MIGRATION ANALYSIS AT 48H

Cells were seeded only to the left of the line and allowed to migrate to the right part for 48h. The arrow indicates the movement of the cells.

KERATINOCYTES MIGRATION ANALYSIS

Key Points

  • Studied in a pre-clinical in vitro human model of gut-skin axis
  • novaBLG1 helps to reduce pro-inflammatory pathways over the gut-skin axis and it promotes the correct balance of the intestinal microbiota
  • It works synergically when combined with GREENIURONIC
  • Scientific paper will be submitted shortly to peer-reviewed journal
  • Without food allergens Reg. 1169/2011
IT EN